An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.
- DOI
- 10.3390/toxins13050334
- Published
- 2021 May 5
- Container
- Toxins
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/toxins13050334,
title = {An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.},
author = {Cosola C and Rocchetti MT and di Bari I and Acquaviva PM and Maranzano V and Corciulo S and Di Ciaula A and Di Palo DM and La Forgia FM and Fontana S and De Angelis M and Portincasa P and Gesualdo L},
year = {2021},
journal = {Toxins},
doi = {10.3390/toxins13050334},
url = {https://doi.org/10.3390/toxins13050334}
}RIS
TY - JOUR TI - An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients. AU - Cosola C AU - Rocchetti MT AU - di Bari I AU - Acquaviva PM AU - Maranzano V AU - Corciulo S AU - Di Ciaula A AU - Di Palo DM AU - La Forgia FM AU - Fontana S AU - De Angelis M AU - Portincasa P AU - Gesualdo L PY - 2021 JO - Toxins DO - 10.3390/toxins13050334 UR - https://doi.org/10.3390/toxins13050334 ER -
APA
C, C., MT, R., I, D. B., PM, A., V, M., S, C., A, D. C., DM, D. P., FM, L. F., S, F., M, D. A., P, P., & L, G. (2021). An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.. Toxins. https://doi.org/10.3390/toxins13050334
Source records
- pubmed · retrieved 2026-09-25T06:09:24.434Z